Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Geraci

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Annali Dell'Istituto Superiore Di Sanita|May 11, 1999
Immigration and health: the Italian situation. Italian National Focal Point (NFP) of the AIDS & Mobility ProjectA Colucci, P Covre, A D'Agostini, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 23, 2003
Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Vasilios Papademetriou, Linda B Piller, Charles E Ford, et al.
The American Journal of Cardiology|July 12, 2007
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialConnie Kingry, Arnaud Bastien, Gillian Booth, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Michael L Jones, David E Gunn, et al.
Controlled Clinical Trials|February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)S L Pressel, B R Davis, J T Wright, et al.
Inorganic Chemistry|January 31, 2026
<i>A</i>-Site Solid Solution Effects on Electrical Resistivity, Oxidation Resistance, and Hardness of MAX Phases V<sub>2</sub>(As<sub>1-<i>x</i></sub>P<sub><i>x</i></sub>)C and V<sub>2</sub>(As<sub>1-<i>x</i></sub>Ge<sub><i>x</i></sub>)CArya Loloee, Manuel Scharrer, Tullio S Geraci, et al.
Giornale Italiano Di Cardiologia|January 15, 1999
Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stentingS De Servi, S Repetto, I Bossi, et al.
Annali Dell'Istituto Superiore Di Sanita|May 24, 2001
Immigration and health: the Italian National Focal Point experienceL Camoni, A Colucci, P Covre, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Profiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivityNicholas S Geraci, Rami M Mukbel, Michael T Kemp, et al.
Oncogene|November 28, 2018
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumorsG Vargas, M Bouchet, L Bouazza, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Annali Dell'Istituto Superiore Di Sanita|May 11, 1999
Immigration and health: the Italian situation. Italian National Focal Point (NFP) of the AIDS & Mobility ProjectA Colucci, P Covre, A D'Agostini, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 23, 2003
Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Vasilios Papademetriou, Linda B Piller, Charles E Ford, et al.
The American Journal of Cardiology|July 12, 2007
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialConnie Kingry, Arnaud Bastien, Gillian Booth, et al.
Journal of Medicinal Chemistry|April 29, 2005
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complicationsMichael C Van Zandt, Michael L Jones, David E Gunn, et al.
Controlled Clinical Trials|February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)S L Pressel, B R Davis, J T Wright, et al.
Inorganic Chemistry|January 31, 2026
<i>A</i>-Site Solid Solution Effects on Electrical Resistivity, Oxidation Resistance, and Hardness of MAX Phases V<sub>2</sub>(As<sub>1-<i>x</i></sub>P<sub><i>x</i></sub>)C and V<sub>2</sub>(As<sub>1-<i>x</i></sub>Ge<sub><i>x</i></sub>)CArya Loloee, Manuel Scharrer, Tullio S Geraci, et al.
Giornale Italiano Di Cardiologia|January 15, 1999
Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stentingS De Servi, S Repetto, I Bossi, et al.
Annali Dell'Istituto Superiore Di Sanita|May 24, 2001
Immigration and health: the Italian National Focal Point experienceL Camoni, A Colucci, P Covre, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Profiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivityNicholas S Geraci, Rami M Mukbel, Michael T Kemp, et al.
Oncogene|November 28, 2018
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumorsG Vargas, M Bouchet, L Bouazza, et al.
Pageof 7